Veeva announced fiscal 2027 first quarter results exceeding guidance
Total revenues were $882.9M, up 16% YoY, and subscription revenues grew 15% to $730.2M. The company also raised its fiscal 2027 guidance.
See the latest news and media coverage for Veeva. We track all announcements, press releases, and industry mentions in real time, all in one place.
Industry cloud for life sciences
veeva.comLast updated
In short: Veeva Systems surpassed revenue expectations for fiscal 2027 and accelerated the rollout of its agentic AI platform, Falcon, for drug development.
Total revenues were $882.9M, up 16% YoY, and subscription revenues grew 15% to $730.2M. The company also raised its fiscal 2027 guidance.
Falcon works with Veeva Development Cloud to reduce costs and speed up processes, focusing on trial master file, regulatory correspondence, and safety case triage.
The agentic CRM provides a commercial foundation for the future, integrating into Merck's data ecosystem.
Teva will adopt the agentic CRM globally, leveraging AI to enhance commercial execution.
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-conviction stock picks and new...
Veeva Systems (NYSE:VEEV) introduced its new Falcon agentic AI platform, detailing capabilities...
Piper Sandler cuts Veeva Systems stock price target on AI timing...
Veeva Systems beats Q1 earnings and revenue estimates, raises fiscal 2027 guidance, and expands AI...
Track Veeva and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Veeva and other trending companies.